A preliminary evaluation of a new enzyme immunoassay to detect Chlamydia pneumoniae-specific antibodies

Journal of Microbiological Methods

Volumn 43, Issue 2, 2000, Pages 117-125

  Ossewaarde, Jacobus M ^a   Tuuminen, Tamara ^b   Boersma, Wim G ^c   Sandström, Mikael ^d   Palomäki, Pekka ^b   Boman, Jens ^d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Thermo Fisher Scientific Oy   (Finland)

^c Location Alkmaar   (Netherlands)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

Antibodies; Enzyme; Immunoassay

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; IMMUNOFLUORESCENCE; MULTICENTER STUDY; PNEUMONIA; PRIORITY JOURNAL;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; REAGENT KITS, DIAGNOSTIC;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0034672771     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7012(00)00220-7     Document Type: Article

References (32)

1. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: the azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia (ACADEMIC) study
2. Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA
3. Respiratory tract infection due to Chlamydia pneumoniae in military personnel
4. Chronic infections and coronary heart disease: is there a link?
5. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland
6. Diagnostic use of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients
7. Infections caused by Chlamydia pneumoniae strain TWAR
8. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
9. An epidemic of a pertussis-like illness caused by Chlamydia pneumoniae
10. Current knowledge of Chlamydia pneumoniae and atherosclerosis
11. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture
12. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide
13. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment
14. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island
15. A sensitive cell line. HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR
16. Chlamydia pneumoniae (TWAR)
17. Bordetella pertussis isolation in general practice: 1977-1979 whooping cough epidemic in West Glamorgan
18. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR)
19. Growth in serum-free medium improves isolation of Chlamydia pneumoniae
20. Workshop on the potential role of infectious agents in cardiovascular disease and atherosclerosis
21. Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis
22. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom free elderly men, but Helicobacter pylori and cytomegalovirus are not
23. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis
24. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results
25. Comparison of two serological methods and a polymerase chain reaction enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults
26. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae
27. Coronary angioplasty induces raise in Chlamydia pneumoniae-specific antibodies
28. Age related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor
29. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA
30. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections
31. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae